Regulus Therapeutics INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
Regulus Therapeutics amends its proxy statement to include details about its engagement with Alliance Advisors LLC for proxy solicitation.
Regulus Therapeutics is holding its annual meeting on May 16, 2024, to vote on director elections, executive compensation, auditor ratification, and an amendment to the equity incentive plan.